A randomized double-blind placebo-controlled clinical trial of a product containing pumpkin seed extract and soy germ extract to improve overactive bladder-related voiding dysfunction and quality of life

Bongseok Shim, Hyewon Jeong, Sara Lee, Sehee Hwang, Byeongseok Moon, Charlotte Storni

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

Overactive bladder (OAB) has become an increasing field of interest. Traditional use indicates that pumpkin seed (Cucurbita pepo L.) may be helpful in combating its symptoms. Additionally, soy isoflavones (Glycine max) are well-documented for hormonal imbalance related indications. The present randomized, double-blind, placebo-controlled study evaluated efficacy and safety of Cucuflavone (containing extracts of pumpkin seed and soy germ) in 120 subjects suffering from OAB. After 12 weeks, subjects taking Cucuflavone experienced a significant reduction versus baseline, in (1) urination frequency, (2) urgency, (3) incontinence frequency, maximum urgency score, (5) nocturnal urination frequency and (6) OAB-symptom scale. The placebo group reached significant differences for (1), (3) and (6). No adverse events or abnormal changes in safety parameters occurred. Thus, the combination of pumpkin seed and soy germ extract can be used as natural alternative to relieve symptoms of OAB and to improve quality of life.

Original languageEnglish
Pages (from-to)111-117
Number of pages7
JournalJournal of Functional Foods
Volume8
Issue number1
DOIs
StatePublished - 2014

Bibliographical note

Funding Information:
This study was supported by Frutarom Switzerland Ltd . We thank Eden Somberg and Rudy Simons for critically reviewing the manuscript.

Keywords

  • Clinical study
  • Cucurbita pepo
  • Incontinence
  • Overactive bladder
  • Pumpkin
  • Soy germ

Fingerprint

Dive into the research topics of 'A randomized double-blind placebo-controlled clinical trial of a product containing pumpkin seed extract and soy germ extract to improve overactive bladder-related voiding dysfunction and quality of life'. Together they form a unique fingerprint.

Cite this